ARCHIVES

FDA Moves To Revoke Avastin’s Breast Cancer Accelerated Approval, Genentech Vows To Fight

This article is from The Cancer Letter archive.

Vol. 36 No. 46 | December 17, 2010

Download PDF Visit The Full Archive

Related Articles

NCI Cooperative Group, Cancer Center Trials Listed

February 29, 2008

Pesticides Not A Risk Factor For Long Island Breast Cancer, Study Finds

September 6, 2002

FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response

July 29, 2011

Sloan-Kettering Sues Empire Blue Cross Over Reimbursement

September 17, 1993

NCAB, President’s Cancer Panel honor the late Paul Calabresi.

June 11, 2004

House: NCI Should Coordinate National Cancer Program

August 4, 1995